Scientific Reports (May 2017)

Monocytic microRNA profile associated with coronary collateral artery function in chronic total occlusion patients

  • Nazanin Hakimzadeh,
  • Joëlle Elias,
  • Gilbert W. M. Wijntjens,
  • Ruud Theunissen,
  • Angela van Weert,
  • Martijn W. Smulders,
  • Nynke van den Akker,
  • Perry D. Moerland,
  • Hein J. Verberne,
  • Loes P. Hoebers,
  • Jose P. S. Henriques,
  • Anja M. van der Laan,
  • Mustafa Ilhan,
  • Mark Post,
  • Sebastiaan C. A. M. Bekkers,
  • Jan J. Piek

DOI
https://doi.org/10.1038/s41598-017-01695-3
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 10

Abstract

Read online

Abstract An expansive collateral artery network is correlated with improved survival in case of adverse cardiac episodes. We aimed to identify cellular microRNAs (miRNA; miR) important for collateral artery growth. Chronic total occlusion (CTO) patients (n = 26) were dichotomized using pressure-derived collateral flow index (CFIp) measurements; high collateral capacity (CFIp > 0.39; n = 14) and low collateral (CFIp < 0.39; n = 12) capacity. MiRNA profiling via next generation sequencing from various monocyte phenotypes (freshly isolated monocytes, monocytes cultured without stimulant, or stimulation with lipopolysaccharide, interleukin 4, transforming growth factor beta-1, or interferon gamma) revealed significantly different miRNA expression patterns between high versus low collateral capacity patients. Validation by real-time polymerase chain reaction demonstrated significantly decreased expression of miR339-5p in all stimulated monocyte phenotypes of low collateral capacity patients. MiR339-5p showed significant correlation with CFIp values in stimulated monocytes. Ingenuity pathway analysis of predicted gene targets of miR339-5p and differential gene expression data from high versus low CFIp patients (n = 20), revealed significant association with STAT3 pathway, and also suggested a possible regulatory role for this signaling pathway. These results identify a novel association between miR339-5p and coronary collateral function. Future work examining modulation of miR339-5p and downstream effects on the STAT3 pathway and subsequent collateral vessel growth are warranted.